Sanofi to Buy Colombian Drugmaker Genfar

Giant French pharmaceutical maker Sanofi said Tuesday it would buy Colombian drugmaker Genfar to expand its product portfolio in South America.

Genfar is Colombia's second-largest manufacturer of generic drugs with sales of $133 million last year, of which 30% was generated outside the country, Sanofi said in a statement announcing the purchase.

"Sanofi has a unique opportunity to strengthen its presence in Latin America through a large portfolio of affordable pharmaceuticals in a broad range of markets," the company's Latin America chief Heraldo Marchezini said in the statement.

Financial terms were not disclosed.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.